Vaccine Science Briefing

The video discusses the work of the CHM's Expert Working Group in evaluating a vaccine. It highlights the diverse expertise involved, the comprehensive data analysis conducted, and the risk-benefit analysis that led to the recommendation for vaccine authorization. The vaccine's effectiveness and safety are emphasized, with a 95% effectiveness rate across various demographics. The video also covers quality control measures and deployment strategies, including storage requirements.

What safety aspects were considered for the vaccine?

What challenges were mentioned regarding the storage of the vaccine?